If you attended AAIC 2012 and need more information on how to obtain CME or CE credits, view the 2012 CME fact sheet.
This activity is jointly sponsored by the Postgraduate Institute for Medicine (PIM) and the Alzheimer's Association.
Scientific sessions are not supported by any commercial entity.
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Postgraduate Institute for Medicine and the Alzheimer's Association. The Postgraduate Institute for Medicine is accredited by the ACCME to provide continuing medical education for physicians.
This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education through the joint sponsorship of Alliant International University (AIU) and the Alzheimer's Association.
Alliant International University (AIU) is approved by the American Psychological Association to sponsor continuing education for psychologists. AIU maintains responsibility for the program and its content. AIU is approved by the California Board of Behavioral Sciences to provide continuing education for MFTs and LCSWs (provider # PCE234). AIU is approved by the California Board of Registered Nursing to provide continuing education for Nurses (provider # CEP11235). AIU is approved the National Board for Certified Counselors (NBCC) to provide continuing education for counselors (provider# 4469). The Alzheimer’s Association maintains responsibility for this program and its content.
The Postgraduate Institute for Medicine designates this live activity for a maximum of 26.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AAIC 2013 is organized by the Alzheimer's Association to foster interdisciplinary interactions among healthcare, research, clinical and administrative professionals concerned with aging and Alzheimer's disease. In addition to core plenary sessions, oral, symposia and poster sessions will be presented to encourage and stimulate diverse viewpoints in research, treatment and care.
After completing this activity, the participant should better be able to:
- Identify advances in technology, including imaging and biomarkers to improve diagnosis and monitor disease progression in Alzheimer's disease
- Review data on current animal models for Alzheimer's disease
- Compare the pathophysiology of aging, Alzheimer's disease and other geriatric syndromes
- Identify potential targets for treatment of Alzheimer's disease
- Discuss recommendations for the prevention of Alzheimer's disease
- Explain therapeutic breakthroughs in neurodegenerative disease
- Identify emerging strategies likely to drive future advances in Alzheimer's disease
- Describe the impact of Alzheimer's on individuals with the disease and their caregivers
- Indicate how Alzheimer's disease affects society as it relates to health economics
- Geriatric psychiatrists
- Geriatric specialists
- Molecular and cell biologists
- Primary care physicians
Disclosure of conflicts of interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by PIM for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.
Americans with Disabilities Act
Event staff will be glad to assist you with any special needs (i.e., physical, dietary, etc). Please contact Alicia Forss prior to the live event at +1.312.335.5866.